During the past 12 months, HLS Therapeutics's average Dividends Per Share Growth Rate was -75.60% per year.
During the past 3 years, the average Dividends Per Share Growth Rate was -19.50% per year.
During the past 5 years, the average Dividends Per Share Growth Rate was 10.60% per year.
During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of HLS Therapeutics was 59.00% per year. The lowest was -19.50% per year. And the median was 22.80% per year.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
HLS Therapeutics Dividend Yield % Historical Data
The historical data trend for HLS Therapeutics's Dividend Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of HLS Therapeutics's Dividend Yield %
For the Drug Manufacturers - Specialty & Generic subindustry, HLS Therapeutics's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
HLS Therapeutics's Dividend Yield % Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, HLS Therapeutics's Dividend Yield % distribution charts can be found below:
* The bar in red indicates where HLS Therapeutics's Dividend Yield % falls into.
HLS Therapeutics Dividend Yield % Calculation
Dividend Yield measures how much a company pays out in dividends each year relative to its share price.
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
Thank you for viewing the detailed overview of HLS Therapeutics's Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.
HLS Therapeutics Inc is a specialty pharmaceutical company. It is focused on the acquisition and commercialization of branded pharmaceutical products in the North American markets. The company products include Clozaril, Vascepa, Trinomia, and Perseris. The company earns revenue in the form of product sales and royalties, out of which product sales contribute to the majority of the revenue. The company operates in Canada, the United States, and the Rest of the world.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
TSX:HLS has been successfully added to your 